Delivery Order SPE2DB22D1200-SPE2DB23FN4DH
Award Date 8/25/23
Potential Completion Date 8/28/23
Potential Value $27K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $6,715.70 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 15, 2023 in support of DLA's medical supply procurement programs. As a leading pharmaceutical distributor, Amerisourcebergen will deliver the requested pharmaceutical product without use of subcontractors. The delivery order was awarded under an...
- The Defense Logistics Agency awarded a $26,862 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML SYRINGEML under a firm fixed price contract. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania by August 21, 2023 to support the Defense Logistics Agency's medical supply needs. No set aside designation or subcontractors were identified. The delivery order was awarded against an...
- The Defense Logistics Agency awarded a $7,817 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania through June 20, 2023 in support of the DLA's medical supply needs. As a top pharmaceutical distributor, Amerisourcebergen will likely draw from established commercial supply chains to deliver the requested pharmaceutical on schedule according to the...
- The Defense Logistics Agency awarded a $100,735.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will deliver the STELARA syringes to a facility in Conshohocken, Pennsylvania by September 28, 2023. No subcontractors or set aside designations were identified. This...
- The Defense Logistics Agency awarded a $17,719 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania to support DLA requirements. STELARA is a biologic medication used to treat autoimmune diseases such as plaque psoriasis and Crohn's disease. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the syringes under its...
- The Defense Logistics Agency awarded a $22,947 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania to support DLA requirements. No additional details were provided regarding the solicitation or overarching contract vehicle. Amerisourcebergen will deliver the pharmaceutical products to the customer agency by July 14, 2023 to meet near-term needs, as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide STELARA 90 MG/ML syringe medication. The $13,471.18 delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of December 29, 2023. This order is not associated with a set-aside program. AmerisourceBergen Drug Corp is an experienced federal contractor, having...
- The Defense Logistics Agency awarded a $14,571.52 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562193987 STELARA 90 MG/ML SYRINGEML. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of DLA's medical materiel needs. Performance will take place in Conshohocken, Pennsylvania from September 15-18, 2023. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen...
- The Defense Logistics Agency awarded a $16,560.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML SYRINGEML. The prime contractor, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill agency requirements between July 20-21, 2023. No subcontractors or set aside designations were identified. The award was issued under an existing DLA contract vehicle to support...
- The Defense Logistics Agency awarded a $36,058.73 firm fixed price delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML SYRINGEML. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will take place in Conshohocken, Pennsylvania from August 16-17, 2023. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the requested STELARA syringes to...
- SPE2DB22D1200Indefinite Delivery Contract
- SPE2DB22D1200-SPE2DB23FN4DHDelivery Order
The Defense Logistics Agency awarded a $26,862 delivery order to Amerisourcebergen Drug Corporation for STELARA 90 MG/ML syringes. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning August 25-28, 2023. As a leading provider of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the requested STELARA doses to support the DLA's medical logistics programs. No set aside designation or subcontractors were identified. The short turnaround reflects the urgency to provide this medication to DLA customers in a timely manner.
Generated 12/19/23, 8:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.9k | 8/25/23 |